Evaluation of Natalizumab for thE Relief of MS Associated FatiGue
Public ClinicalTrials.gov record NCT00464074. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Multi-center, Open-Label Study to Evaluate the Effects of Natalizumab Treatment on Fatigue and Cognition in Subjects With Relapsing Forms of MS
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study aims to study the effects of TYSABRI® treatment on fatigue and cognition in patients with relapsing forms of MS.
Study identification
- NCT ID
- NCT00464074
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 89 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 18 Years to 55 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 1, 2007 (Actual)
- Primary completion
- Jul 31, 2010 (Actual)
- Completion
- Jul 31, 2010 (Actual)
- Last update posted
- Aug 22, 2023
2007 – 2010
United States locations
- U.S. sites
- 30
- U.S. states
- 19
- U.S. cities
- 28
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Phoenix | Arizona | 85006 | — |
| Research Site | Fresno | California | 93720 | — |
| Research Site | Atlanta | Georgia | 30327 | — |
| Research Site | Idaho Falls | Idaho | 83404 | — |
| Research Site | Evanston | Illinois | 60201 | — |
| Research Site | Lake Barrington | Illinois | 60010 | — |
| Research Site | Indianapolis | Indiana | 46256 | — |
| Research Site | West Des Moines | Iowa | 50314 | — |
| Research Site | Lexington | Kentucky | 40503 | — |
| Research Site | Louisville | Kentucky | 40202 | — |
| Research Site | Boston | Massachusetts | 02135 | — |
| Research Site | Lexington | Massachusetts | 02421 | — |
| Research Site | Farmington Hills | Michigan | 48334 | — |
| Research Site | Buffalo | New York | 14203 | — |
| Research Site | New York | New York | 10003 | — |
| Research Site | Patchogue | New York | 11772 | — |
| Research Site | Chapel Hill | North Carolina | 27599 | — |
| Research Site | High Point | North Carolina | 27262 | — |
| Research Site | Raleigh | North Carolina | 27607 | — |
| Research Site | Portland | Oregon | 97225 | — |
| Research Site | Anderson | South Carolina | 29621 | — |
| Research Site | Franklin | Tennessee | 37064 | — |
| Research Site | Knoxville | Tennessee | 37934 | — |
| Research Site | Nashville | Tennessee | 37205 | — |
| Research Site | Nashville | Tennessee | 37212 | — |
| Research Site | Salt Lake City | Utah | 84103 | — |
| Research Site | Salt Lake City | Utah | 84108 | — |
| Research Site | Seattle | Washington | 98195 | — |
| Research Site | Charleston | West Virginia | 25301 | — |
| Research Site | Waukesha | Wisconsin | 53188 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00464074, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 22, 2023 · Synced Nov 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00464074 live on ClinicalTrials.gov.